GOLD severity stratification and risk of hospitalisation for COPD exacerbations

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 69, Issue 4, 2008, Pages 164-169

  Lusuardi, Mirco ^a   Lucioni, C ^b   De Benedetto, F ^c   Mazzi, S ^b   Sanguinetti, C M ^d   Donner, C F ^e  

^a PATHOLOGY UNIT   (Italy)

^b Wolters Kluwer Health/ADIS International   (Italy)

^c UOC di Pneumologia PO SS Annunziata ASL Chieti   (Italy)

^d SAN FILIPPO NERI HOSPITAL   (Italy)

^e Mondo Medico   (Italy)

Author keywords

Chronic obstructive pulmonary disease; Exacerbations; Hospitalisation; Risk factors; Severity stratification

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; OXYGEN; THEOPHYLLINE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH CARE COST; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; TELEPHONE;

EID: 62549104819     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2008.378     Document Type: Article

References (23)

1. Miravitlles M, Murio C, Guerriero T, Gisbert R, for the DAFNE Study Group. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002; 121: 1449-1455.
2. Garcia-Aymerich J, Monsò E, Marrades RM, et al. Risk Factors for Hospitalisation for a Chronic Obstructive Pulmonary Disease Exacerbation. EFRAM STUDY. Am J Respir Crit Care Med 2001; 164: 1002-1007.
3. Garcia-Aymerich J, Farrero E, Felez MA, et al. Risk factors for readmision to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58: 100-105.
4. Roberts CM, Lowe D, Bucknall CE, Ryland I, Kelly Y, Pearson MG, on behalf of the British Thoracic Society Audit sub-committee of the standards of care committee and the Royal College of Physicians of London. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002; 57: 137-141.
5. Lucioni C, Donner CF, De Benedetto F, et al. I costi della broncopneumopatia cronica ostruttiva in Italia: la fase prospettica dello studio ICE. Pharmacoeconomics Italian Research Articles 2005, 7: 119-134.
6. Lusuardi M, Lucioni C, Donner CF. Costs related to COPD exacerbations in Italy. Multidisciplinary Respiratory Medicine 2008; 1: 60-62.
7. American Thoracic Society. Standardizzazione della spirometria. Translation by Scalera AR, Di Pede F, Viegi G. Pacini Editore, Pisa, 1996.
8. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available from: http://www.goldcopd.org. (accessed 5/5/2004).
9. Mannino, DM, Gagnon, RC, Petty, TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160: 1683-1689.
10. Price LC, Lowe D, Hosker HSR, Anstey K, Pearson MG, Roberts CM, on behalf of the British Thoracic Society and the Royal College of Physicians Clinical Effectiveness Evaluation Unit (CEEu). UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax 2006; 61: 837-842.
11. Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 959-967.
12. Almagro P, Calbo E, Ochoa de Echaguen A, et al. Mortality after hospitalisation for COPD. Chest 2002; 121: 1441-1448.
13. Gunen H, Hacievliyagil SS, Kosar F, et al. Factors affecting survival of hospitalised patients with COPD. Eur Respir J 2005; 26: 234-241.
14. Ong K-H, Earnest A, Lu S-J. A multidimensional grading system (BODE Index) as predictor of hospitalisation for COPD. Chest 2005; 128: 3810-3816.
15. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J 2006; 28: 1245-1257.
16. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
17. Sanguinetti CM, Corrao G, Ochan Bilama M, et al. An Italian investigation of pathogens causing COPD exacerbation and their resistance to common antibiotics (The EOLO Study). Multidisciplinary Respiratory Medicine 2008; 1: 13-21.
18. Quon BS, Gan WQ, Sin DD. Contemporary management of acute exacerbations of COPD. Chest 2008; 133: 756-766.
19. Niewoehner DE, Lokhnygina Y, Rice K, et al. Risk indexes for exacerbations and hospitalisations due to COPD. Chest 2007; 131: 20-28.
20. Casas A, Troosters T, Garcia-Aymerich J, et al. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J 2006; 28: 123-130.
21. Lareau SC. Importance of functional performance assessment for severe COPD. Multidisciplinary Respiratory Medicine 2008; 1: 30-33.
22. Han MLK, Kim MG, Mardon R, et al. Spirometry utilization for COPD. How do we measure up? Chest 2007; 132: 403-409.
23. Lusuardi M, Orlandini D. Underutilization of spirometry for the diagnosis of COPD. Chest 2008; 133; 313-314.